Tempus to Present Nine Abstracts at 2024 SITC Annual Meeting
Tempus AI, Inc. (NASDAQ: TEM), a leader in applying artificial intelligence to drive advancements in precision medicine and patient care, today announced that nine of its abstracts have been accepted…
Mirum Pharmaceuticals Announces Inducement Grants Under Nasdaq Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) announced that on November 8, 2024, its Compensation Committee granted inducement awards to seven new employees under the company’s 2020 Inducement Plan. These awards consist…
Baxter Reports Q3 2024 Results
Baxter International Inc. (NYSE: BAX), a global leader in medical technology, announced today its financial results for the third quarter of 2024, highlighting strong performance despite ongoing challenges. “Despite facing…
Cencora Expands Specialty Leadership with Acquisition of Retina Consultants of America
Cencora, Inc. (NYSE: COR), a global leader in pharmaceutical solutions, today announced it has entered into a definitive agreement to acquire Retina Consultants of America (RCA), a leading management services…
ZAP Surgical Raises $78M in Series E Funding Led by Baheal Medical
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, announced today the successful closing of a $78 million Series E funding round, led by Qingdao Baheal Medical…
Castle Biosciences to Present New Data on DecisionDx®-Melanoma and MyPath® Melanoma at ASDP 61st Annual Meeting
Castle Biosciences, Inc. (Nasdaq: CSTL), a leader in developing innovative tests to guide patient care, will present new data on the clinical performance of its DecisionDx®-Melanoma and MyPath® Melanoma tests…
Palleon Pharmaceuticals Presents GLIMMER-01 Trial Results of E-602 and Cemiplimab at SITC Annual Meeting
Palleon Pharmaceuticals, a clinical-stage company leading innovation in glyco-immunology for autoimmune diseases and cancer, today announced results from the Phase 1/2 GLIMMER-01 trial of E-602. This first-in-class human sialidase enzyme…
Sunshine Health Announces Charlene Zein President and CEO
Sunshine Health, Florida’s largest managed care organization and a subsidiary of Centene Corporation (NYSE: CNC), has announced the appointment of Charlene Zein as Plan President and Chief Executive Officer, effective…
Tempus Launches Clinical Immune Profile Score Test
Tempus AI, Inc. (NASDAQ: TEM), a leader in AI-driven precision medicine, has announced the clinical launch of its Immune Profile Score (IPS) algorithmic test. Now available for clinicians to order,…
Square Knot Health Enhances Kidney Transplant Access, Reports at ASN Kidney Week
Square Knot Health, a leader in technology-driven kidney transplant care, has achieved outstanding results with its innovative care model designed to help patients navigate the complexities of kidney transplantation. The…
Cofactor Genomics Publishes Clinical Validation of OncoPrism-HNSCC Immunotherapy Test
Cofactor Genomics, Inc., a clinical-stage company focused on advancing precision medicine through RNA decoding, has announced the publication of results from its PREDAPT clinical trial (NCT04510129) in head and neck…
Maravai to Acquire Officinae Bio’s DNA and RNA Business
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services, has announced an agreement to acquire the DNA and RNA business of Officinae Bio. This acquisition…